Clinical Trials Browser

Phase 3 × Melanoma × Lenalidomide × Clear all

NCT00057616 2019-11-08

Study to Compare the Efficacy and Safety of CC-5013 vs. Placebo in Subjects With Metastatic Malignant Melanoma.

Phase 3 Completed

Melanoma, Neoplasm Metastasis